V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001912 | 230006500 | 1.66 | 78.1 | null | 2019-05-04 | 2019-05-26 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100304164 |
| 230001914 | 230006501 | null | null | Adjuvant (A) | 2018-10-08 | 2018-10-13 | Rucaparib | 02 | N | RUCAPARIB | 100989179 |
| 230001916 | 230006503 | null | null | null | null | 2021-12-12 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100592802 |
| 230001917 | 230006504 | null | null | null | 2016-11-08 | 2016-11-24 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101627896 |
| 230001918 | 230006505 | 1.59 | 65.6 | null | 2019-10-21 | 2019-10-22 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100582915 |
| 230001920 | 230006507 | 1.64 | 54.3 | null | 2017-12-26 | 2018-01-16 | null | null | null | OLAPARIB | 100603306 |
| 230001923 | 230006508 | 1.57 | 90 | null | null | 2019-07-01 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101165281 |
| 230001925 | 230006509 | 1.6 | 57.5 | Adjuvant (A) | 2020-01-29 | 2020-02-13 | Niraparib | 02 | N | NIRAPARIB | 100276572 |
| 230001926 | 230006510 | null | null | null | 2017-09-21 | 2017-10-05 | CARBOPLATIN | 01 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101443646 |
| 230001928 | 230006512 | 1.62 | 56.4 | null | 2020-02-15 | 2020-04-02 | null | null | null | NIRAPARIB | 100082218 |
| 230001934 | 230006517 | null | null | null | null | 2019-09-18 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100402330 |
| 230001937 | 230006520 | null | null | Palliative (P) | 2020-06-28 | 2020-07-18 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100042240 |
| 230001938 | 230006521 | null | null | null | null | 2020-02-23 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101134945 |
| 230001940 | 230006523 | null | 89.6 | Adjuvant (A) | 2022-01-17 | 2022-01-24 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101063662 |
| 230001943 | 230006526 | 1.5 | 111 | Palliative (P) | 2018-10-28 | 2018-11-25 | null | null | N | NIRAPARIB | 100429649 |
| 230001945 | 230006528 | 1.67 | 53.2 | null | 2021-08-29 | 2021-09-21 | null | 99 | null | IPILIMUMAB + NIVOLUMAB | 101799109 |
| 230001947 | 230006529 | 1.62 | 55.3 | Palliative (P) | 2019-06-24 | 2020-01-24 | null | null | N | RUCAPARIB | 100662507 |
| 230001948 | 230006530 | null | null | Palliative (P) | null | 2017-09-06 | null | null | N | IPILIMUMAB + NIVOLUMAB | 100617939 |
| 230001949 | 230006531 | 1.44 | 61.4 | null | 2021-03-20 | 2021-08-13 | Liposomal Doxorubicin (Caelyx) | 02 | null | LIPOSOMAL DOXORUBICIN | 101329345 |
| 230001950 | 230006532 | 1.52 | 42.9 | null | 2016-05-10 | 2016-05-10 | null | null | null | PEMBROLIZUMAB | 101174225 |
| 230001952 | 230006533 | 1.57 | 98.7 | null | 2020-11-15 | 2020-11-19 | Liposomal Doxorubicin (Caelyx) | 02 | null | LIPOSOMAL DOXORUBICIN | 101302845 |
| 230001953 | 230006534 | 1.63 | 71.7 | Palliative (P) | null | 2019-05-12 | Olaparib | 02 | N | OLAPARIB | 101786368 |
| 230001955 | 230006536 | 1.64 | 71.5 | Palliative (P) | null | 2021-02-06 | null | null | Y | OLAPARIB | 100203421 |
| 230001956 | 230006537 | 1.72 | 71.6 | Palliative (P) | null | 2019-06-18 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100717977 |
| 230001957 | 230006538 | 1.59 | 67.4 | null | 2018-03-05 | 2019-12-28 | null | null | null | PEMBROLIZUMAB | 100273956 |
| 230001959 | 230006540 | 1.53 | 87.3 | null | 2021-05-06 | 2021-05-19 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100633551 |
| 230001961 | 230006541 | 1.51 | 54.6 | Palliative (P) | 2019-08-18 | 2019-08-25 | Rucaparib | 02 | N | RUCAPARIB | 101311040 |
| 230001962 | 230006542 | 1.59 | 74.6 | null | 2021-10-30 | 2021-11-22 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100938425 |
| 230001963 | 230006543 | 1.66 | 68 | null | 2020-05-13 | 2020-07-30 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101356190 |
| 230001965 | 230006544 | 1.78 | 50.4 | null | null | 2017-04-26 | Olaparib | 02 | null | OLAPARIB | 100648169 |
| 230001966 | 230006545 | null | null | null | null | 2019-03-25 | Liposomal Doxorubicin (Caelyx) | 02 | null | LIPOSOMAL DOXORUBICIN | 101170545 |
| 230001970 | 230006546 | null | null | Palliative (P) | null | 2019-05-23 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101242366 |
| 230001974 | 230006549 | 1.72 | 61.5 | null | null | 2019-12-05 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101563949 |
| 230001976 | 230006551 | null | null | null | 2021-08-12 | 2021-08-19 | null | null | null | TRABECTEDIN | 101770881 |
| 230001977 | 230006552 | 1.48 | 46.4 | Adjuvant (A) | null | 2020-03-09 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 101623618 |
| 230001978 | 230006553 | null | null | Palliative (P) | 2020-07-11 | 2020-07-16 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100327927 |
| 230001980 | 230006554 | 1.62 | 69.9 | Palliative (P) | 2019-08-04 | 2020-01-08 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100048421 |
| 230001982 | 230006555 | 1.62 | 65.9 | null | 2017-02-07 | 2017-05-20 | null | null | null | CAPECITABINE | 101163629 |
| 230001984 | 230006556 | 1.59 | null | null | null | 2019-10-06 | null | null | null | PEMBROLIZUMAB | 101583148 |
| 230001986 | 230006558 | 1.65 | 63.8 | Palliative (P) | 2019-07-07 | 2019-07-21 | null | null | N | CARBOPLATIN | 101362307 |
| 230001987 | 230006559 | null | null | Adjuvant (A) | null | 2017-04-22 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100641405 |
| 230001988 | 230006560 | 1.65 | 59.5 | null | 2019-01-29 | 2019-04-02 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100478120 |
| 230002000 | 230006565 | 1.71 | 78.7 | null | 2016-04-07 | 2017-02-15 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100920536 |
| 230002001 | 230006566 | 1.47 | 66.55 | null | 2016-03-21 | 2016-06-04 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 101026002 |
| 230002003 | 230006568 | 1.66 | 0 | null | 2021-05-11 | 2021-05-24 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 100970893 |
| 230002005 | 230006570 | 1.66 | 86 | Palliative (P) | 2018-11-09 | 2020-09-28 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100833224 |
| 230002009 | 230006572 | null | null | null | 2020-11-25 | 2020-11-27 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101147678 |
| 230002010 | 230006573 | 1.61 | 70.8 | null | 2021-04-01 | 2021-04-09 | null | null | null | NAB-PACLITAXEL | 100796228 |
| 230002011 | 230006574 | 1.57 | 94.1 | null | 2019-09-24 | 2019-10-13 | null | null | null | PACLITAXEL | 100575094 |
| 230002012 | 230006575 | null | null | null | null | 2020-07-15 | Niraparib | 02 | null | NIRAPARIB | 100438490 |